• English
  • Svenska
  • DRUG DEVELOPERS

PRECISION MONITORING IN CANCER CARE

How do cancer patients respond to treatment? TK1 as biomarker in cancer care can help clinicians make timely and decisions about ongoing treatment of every patient.

Read more

DRUG DISCOVERY AND DEVELOPMENT

Measurement of proliferation, or progression and remission of tumor growth is in the drug discovery. AroCell TK 210 ELISA, opens the opportunity to monitor the efficacy and dose response of drug candidates in drug discovery.

Read more

CANCER TREATMENT IS COMPLICATED. AROCELL TK 210 ELISA ISN’T

Arocell TK 210 ELISA is a simple test designed for the determination of TK1 in human blood. It is easy to use, robust and requires no special instrumentation to perform.

Read more

SO YOU THINK YOU KNOW TK1? - THE UNIQUE BIOMARKER

Increased levels of TK1 in the blood can indicate active cell proliferation as a consequence of abnormal cell turnover and cell disruption triggered by for example drug and  therapeutic agents.

Read more

SCIENTIFIC REFERENCES

An extensive list of published articles on applications, Thymidine Kinase 1 and use of AroCell TK 210 ELISA.

Read more

CLINICAL STUDIES

AroCell is participating in several clinical studies, both with partners and independently.

Read more

Subscription for news and press releases

We use cookies to improve the user experience and gather anonymous visitor statistics. By using our website, you agree to the use of cookies.

I agree.